+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Gastroretentive Drug Delivery Systems Market Size, Share & Trends Analysis Report by Type (Tablets, Liquid, Capsule), by Dosage Form, by Distribution Channel, by Region, and Segment Forecasts, 2021-2028

  • ID: 5415579
  • Report
  • April 2021
  • Region: Global
  • 150 Pages
  • Grand View Research

FEATURED COMPANIES

  • Depomed
  • F. Hoffmann La Roche
  • GlaxoSmithKline
  • Pharmacia
  • Ranbaxy

The global gastroretentive drug delivery systems market size is estimated to reach USD 19.7 billion by 2028, registering a CAGR of 6.4%. Gastroretentive Drug Delivery Systems (DDSs) offer possible advantages for the drug with poor bioavailability, as their absorption is restricted to the upper Gastrointestinal Tract (GIT) and can be delivered proficiently. Hence enhancing absolute bioavailability and maximizing its absorption is expected to boost market growth during the forecast period.



Several advantages of these DDSs include curative efficiency and an increase in the bioavailability of drugs. The controlled and systematic DDS minimizes the chances of medicine overexposure at the diseased site. It also offers higher efficiency owing to reduced counter activity by the body. Hence, various advantages associated with gastroretentive DDSs are expected to foster the overall market progression.

The DDS sustains the release of drugs and avails local therapy in the small intestine and stomach. The method is useful in the treatment of various disorders related to the small intestine and stomach. Rising cases of stomach and small intestine-related disorders are anticipated to foster the demand for such efficient DDSs. According to the Endoscopy Center, each year around 62.0 million people are diagnosed with digestive disorders. The prevalence of most digestive disorders increases with age, creating demand for novel healthcare systems among adults and the geriatric population.

These DDSs are effective in treating duodenal and gastric ulcers, including esophagitis, by eliminating deeply buried helicobacter pylori from the submucosal tissue of the stomach. Apart from this, GRDDSs release the medicine slowly in the stomach and preserve its effective concentration in systemic circulation for a prolonged period of time. Hence, the above-mentioned factors are predicted to augment market expansion.

Gastroretentive Drug Delivery Systems Market Report Highlights

  • The floating drug delivery systems held the largest market share in 2020
  • These systems have a lower density than gastric fluids and hence stay buoyant in the stomach without altering the gastric emptying rate for a long time
  • The liquid dosage form segment is expected to grow at the fastest rate during the forecast period due to the availability of a wide range of liquid-based gastroretentive products in treating all types of gastric disorders
  • The online pharmacies segment is predicted to witness the fastest growth rate over the forecast timeframe as they offer a wide range of options along with in-depth drug information
  • North America held the largest market share and is anticipated to maintain its dominance over the forecast period
  • This is attributable to the growing prevalence of H. Pylori infection, increasing R&D expenditure, and rising technological advancements in gastroretentive DDSs
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Depomed
  • F. Hoffmann La Roche
  • GlaxoSmithKline
  • Pharmacia
  • Ranbaxy

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Dosage form
1.1.3. Distribution channel
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary
2.1. Market Outlook

Chapter 3. Gastroretentive Drug Delivery Systems Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Rising number of H. Pylori infection
3.4.1.2. Increasing advantages of gastroretentive drug delivery system
3.4.1.3. Technological advancements
3.4.2. Market restraint analysis
3.4.2.1. Availability of alternative drug delivery systems
3.5. Gastroretentive Drug Delivery Systems Market Analysis Tools
3.5.1. Industry analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies

Chapter 4. Global Gastroretentive Drug Delivery Systems market: Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. High Density System
4.1.2. Expandable Drug Delivery System
4.1.3. Bioadhesive Drug Delivery System
4.1.4. Floating Drug Delivery System
4.1.5. Others
4.2. Type Market Share, 2020 & 2028
4.3. Segment Dashboard
4.4. Global Gastroretentive Drug Delivery Systems Market by Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.5.1. High Density System
4.5.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
4.5.2. Expandable Drug Delivery System
4.5.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
4.5.3. Bioadhesive Drug Delivery System
4.5.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
4.5.4. Floating Drug Delivery System
4.5.4.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
4.5.5. Others
4.5.5.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)

Chapter 5. Global Gastroretentive Drug Delivery Systems Market: Dosage Form Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Tablets
5.1.2. Liquid
5.1.3. Microspheres
5.1.4. Capsule
5.1.5. Others
5.2. Dosage Form Market Share, 2020 & 2028
5.3. Segment Dashboard
5.4. Global Gastroretentive Drug Delivery Systems Market by Dosage Form Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.5.1. Tablets
5.5.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
5.5.2. Liquid
5.5.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
5.5.3. Microspheres
5.5.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
5.5.4. Capsule
5.5.4.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
5.5.5. Others
5.5.5.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)

Chapter 6. Global Gastroretentive Drug Delivery Systems market: Distribution Channel Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospital Pharmacies
6.1.2. Retail Pharmacies
6.1.3. Online Pharmacies
6.2. Distribution Channel Market Share, 2020 & 2028
6.3. Segment Dashboard
6.4. Global Gastroretentive Drug Delivery Systems Market by Distribution Channel Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
6.5.1. Hospital Pharmacies
6.5.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.5.2. Retail Pharmacies
6.5.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.5.3. Online Pharmacies
6.5.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)

Chapter 7. Global Gastroretentive Drug Delivery Systems market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2020 & 2028
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2020 to 2028:
7.7. North America
7.7.1. U.S.
7.7.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.7.2. Canada
7.7.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.8. Europe
7.8.1. U.K.
7.8.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.8.2. Germany
7.8.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.8.3. France
7.8.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.8.4. Italy
7.8.4.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.8.5. Spain
7.8.5.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.9. Asia Pacific
7.9.1. Japan
7.9.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.9.2. China
7.9.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.9.3. India
7.9.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.9.4. South Korea
7.9.4.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.9.5. Australia
7.9.5.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.10.2. Mexico
7.10.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.10.3. Argentina
7.10.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.10.4. Columbia
7.10.4.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.11. MEA
7.11.1. South Africa
7.11.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.11.2. Saudi Arabia
7.11.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competitive Categorization
8.2.1. Innovators
8.2.2. Market leaders
8.2.3. Emerging players
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2020
8.4. Public Companies
8.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
8.4.2. Company market share/ranking, by region
8.4.3. Competitive dashboard analysis
8.4.3.1. Market differentiators
8.4.3.2. Synergy analysis: major deals and strategic alliances
8.5. Private Companies
8.5.1. List of key emerging companies/technology disruptors/innovators
8.5.2. Funding outlook
8.5.3. Regional network map
8.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
8.5.5. Supplier ranking
8.5.6. Key company profiled
8.5.7. F. Hoffmann La Roche
8.5.7.1. Company overview
8.5.7.2. Financial performance
8.5.7.3. Product benchmarking
8.5.7.4. Strategic initiatives
8.5.8. Ranbaxy
8.5.8.1. Company overview
8.5.8.2. Financial performance
8.5.8.3. Product benchmarking
8.5.8.4. Strategic initiatives
8.5.9. GlaxoSmithKline
8.5.9.1. Company overview
8.5.9.2. Financial performance
8.5.9.3. Product benchmarking
8.5.9.4. Strategic initiatives
8.5.10. Pharmacia
8.5.10.1. Company overview
8.5.10.2. Financial performance
8.5.10.3. Product benchmarking
8.5.10.4. Strategic initiatives
8.5.11. Depomed
8.5.11.1. Company overview
8.5.11.2. Financial performance
8.5.11.3. Product benchmarking
8.5.11.4. Strategic initiatives

List of Tables
Table 1 List of Abbreviation
Table 2 North America gastroretentive drug delivery systems market, by region, 2016 - 2028 (USD Million)
Table 3 North America gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 4 North America gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 5 North America gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 6 U.S. gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 7 U.S. gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 8 U.S. gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 9 Canada gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 10 Canada gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 11 Canada gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 12 Europe gastroretentive drug delivery systems market, by region, 2016 - 2028 (USD Million)
Table 13 Europe gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 14 Europe gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 15 Europe gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 16 U.K gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 17 U.K gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 18 U.K gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 19 Germany gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 20 Germany gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 21 Germany gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 22 France gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 23 France gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 24 France gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 25 Italy gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 26 Italy gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 27 Italy gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 28 Spain gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 29 Spain gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 30 Spain gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 31 Asia Pacific gastroretentive drug delivery systems market, by region, 2016 - 2028 (USD Million)
Table 32 Asia Pacific gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 33 Asia Pacific gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 34 Asia Pacific gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 35 Japan gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 36 Japan gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 37 Japan gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 38 China gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 39 China gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 40 China gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 41 India gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 42 India gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 43 India gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 44 South Korea gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 45 South Korea gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 46 South Korea gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 47 Australia gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 48 Australia gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 49 Australia gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 50 Latin America gastroretentive drug delivery systems market, by region, 2016 - 2028 (USD Million)
Table 51 Latin America gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 52 Latin America gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 53 Latin America gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 54 Brazil gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 55 Brazil gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 56 Brazil gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 57 Mexico gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 58 Mexico gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 59 Mexico gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 60 Argentina gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 61 Argentina gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 62 Argentina gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 63 Columbia gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 64 Columbia gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 65 Columbia gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 66 Middle East & Africa gastroretentive drug delivery systems market, by region, 2016 - 2028 (USD Million)
Table 67 Middle East & Africa gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 68 Middle East & Africa gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 69 Middle East & Africa gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 70 South Africa gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 71 South Africa gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 72 South Africa gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 73 Saudi Arabia gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 74 Saudi Arabia gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 75 Saudi Arabia gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)
Table 76 UAE gastroretentive drug delivery systems market, by type, 2016 - 2028 (USD Million)
Table 77 UAE gastroretentive drug delivery systems market, by dosage form, 2016 - 2028 (USD Million)
Table 78 UAE gastroretentive drug delivery systems market, by distribution channel, 2016 - 2028 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Gastroretentive drug delivery systems market: market outlook
Fig. 14 Gastroretentive drug delivery systems market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Gastroretentive drug delivery systems market driver impact
Fig. 20 Gastroretentive drug delivery systems market restraint impact
Fig. 21 Gastroretentive drug delivery systems market strategic initiatives analysis
Fig. 22 Gastroretentive drug delivery systems market: type movement analysis
Fig. 23 Gastroretentive drug delivery systems market: type outlook and key takeaways
Fig. 24 High density systems market estimates and forecast, 2016 - 2028
Fig. 25 Expandable drug delivery systems market estimates and forecast, 2016 - 2028
Fig. 26 Bioadhesive drug delivery systems market estimates and forecast, 2016 - 2028
Fig. 27 Floating drug delivery systems market estimates and forecast, 2016 - 2028
Fig. 28 Others market estimates and forecast, 2016 - 2028
Fig. 29 Gastroretentive drug delivery systems market: dosage form movement analysis
Fig. 30 Gastroretentive drug delivery systems market: dosage form outlook and key takeaways
Fig. 31 Liquid market estimates and forecast, 2016 - 2028
Fig. 32 Tablets market estimates and forecast, 2016 - 2028
Fig. 33 Capsule market estimates and forecast, 2016 - 2028
Fig. 34 Microspheres market estimates and forecast, 2016 - 2028
Fig. 35 Others market estimates and forecast, 2016 - 2028
Fig. 36 Gastroretentive drug delivery systems market: distribution channel movement analysis
Fig. 37 Gastroretentive drug delivery systems market: distribution channel outlook and key takeaways
Fig. 38 Hospital pharmacies market estimates and forecast, 2016 - 2028
Fig. 39 Retail pharmacies market estimates and forecast, 2016 - 2028
Fig. 40 Online pharmacies market estimates and forecast, 2016 - 2028
Fig. 41 Global gastroretentive drug delivery systems market: regional movement analysis
Fig. 42 Global gastroretentive drug delivery systems market: regional outlook and key takeaways
Fig. 43 Global gastroretentive drug delivery systems market share and leading players
Fig. 44 North America market share and leading players
Fig. 45 Europe market share and leading players
Fig. 46 Asia Pacific market share and leading players
Fig. 47 Latin America market share and leading players
Fig. 48 Middle East & Africa market share and leading players
Fig. 49 North America: SWOT
Fig. 50 Europe SWOT
Fig. 51 Asia Pacific SWOT
Fig. 52 Latin America SWOT
Fig. 53 MEA SWOT
Fig. 54 North America, by country
Fig. 55 North America
Fig. 56 North America market estimates and forecast, 2016 - 2028
Fig. 57 U.S.
Fig. 58 U.S. market estimates and forecast, 2016 - 2028
Fig. 59 Canada
Fig. 60 Canada market estimates and forecast, 2016 - 2028
Fig. 61 Europe
Fig. 62 Europe market estimates and forecast, 2016 - 2028
Fig. 63 U.K.
Fig. 64 U.K. market estimates and forecast, 2016 - 2028
Fig. 65 Germany
Fig. 66 Germany market estimates and forecast, 2016 - 2028
Fig. 67 France
Fig. 68 France market estimates and forecast, 2016 - 2028
Fig. 69 Italy
Fig. 70 Italy market estimates and forecast, 2016 - 2028
Fig. 71 Spain
Fig. 72 Spain market estimates and forecast, 2016 - 2028
Fig. 73 Asia Pacific
Fig. 74 Asia Pacific market estimates and forecast, 2016 - 2028
Fig. 75 China
Fig. 76 China market estimates and forecast, 2016 - 2028
Fig. 77 Japan
Fig. 78 Japan market estimates and forecast, 2016 - 2028
Fig. 79 India
Fig. 80 India market estimates and forecast, 2016 - 2028
Fig. 81 Australia
Fig. 82 Australia market estimates and forecast, 2016 - 2028
Fig. 83 South Korea
Fig. 84 South Korea market estimates and forecast, 2016 - 2028
Fig. 85 Latin America
Fig. 86 Latin America market estimates and forecast, 2016 - 2028
Fig. 87 Brazil
Fig. 88 Brazil market estimates and forecast, 2016 - 2028
Fig. 89 Mexico
Fig. 90 Mexico market estimates and forecast, 2016 - 2028
Fig. 91 Argentina
Fig. 92 Argentina market estimates and forecast, 2016 - 2028
Fig. 93 Columbia
Fig. 94 Columbia market estimates and forecast, 2016 - 2028
Fig. 95 Middle East and Africa
Fig. 96 Middle East and Africa. market estimates and forecast, 2016 - 2028
Fig. 97 South Africa
Fig. 98 South Africa market estimates and forecast, 2016 - 2028
Fig. 99 Saudi Arabia
Fig. 100 Saudi Arabia market estimates and forecast, 2016 - 2028
Fig. 101 UAE
Fig. 102 UAE market estimates and forecast, 2016 - 2028
Fig. 103 Participant categorization- gastroretentive drug delivery systems market
Fig. 104 Market share of key market players- gastroretentive drug delivery systems market

Note: Product cover images may vary from those shown
  • F. Hoffmann La Roche
  • GlaxoSmithKline
  • Ranbaxy
  • Pharmacia
  • Depomed
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll